Tumor cells express surface molecules associated with tumor immunity, especially immune checkpoints such as PD-L1, CTLA-4, and CD276, which play important roles in regulating antitumor immunity by costimulating or coinhibiting the killing effect of T cells and are thus key targets for immunotherapy. This evidence concerns the gene CTLA4 and neoplasm.